The Biosimilars and Biologics Market is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032. FMI, in its business report, elaborates on the historical and current scenario of the global Biosimilars …
Category Archives: Healthcare Trends
Automated Sample Storage Systems Market Soars: FMI Forecasts 11.6% CAGR, Crossing US$ 3.2 Billion Mark by 2033
In 2022, the projected scale of the automated sample storage systems market amounted to US$ 1004.7 million, with an estimated increase to US$ 1100 million in 2023, demonstrating a robust compound annual growth rate (CAGR) of 11.6%. The growth of automated sample storage systems can be attributed to several factors, including their ability to enhance …
Breath Analyzers Market Accelerates to US$ 3.40 Billion Valuation by 2032, FMI’s Analysis Unveils a Resilient 17% CAGR Trend
The breath analyzers market is projected liable to enroll a CAGR of 17% during the gauge time frame, up from US$ 613 Mn in 2021 to arrive at a valuation of US$ 3.40 Bn by 2032. The Global Breath Analyzers Market study provides critical information related to the global, regional, and top players including Breath Analyzers …
Life Science and Chemical Instruments Market Poised for 5.3% CAGR Surge by 2032 | According to FMI Analysis
The Life Science and Chemical Instruments Market is anticipated to increase from US$ 40.7 million in 2021 to US$ 43.8 million in 2026, with a CAGR of 5.3% from 2022 to 2032. Life science and chemical instruments have major applications in research and development centers, educational institutes, and clinical laboratories. The life science and chemical instruments market is dependent …
FMI’s Revelation: Injectable Drugs Market Surging with a CAGR of 5.8% Towards US$ 937.0 Billion by 2032
The global injectable drugs market is poised to attain a value of US$ 531.8 billion by 2022. Projections indicate that market sales will maintain a steady growth trajectory, with a Compound Annual Growth Rate (CAGR) of 5.8%, culminating in an estimated value of US$ 937.0 billion by 2032. A recent study conducted by Future Market …
Diabetic Retinopathy Market: A Bright Outlook with an Expected CAGR of 5.8% Leading to US$ 15.50 Billion by 2033 | FMI
The diabetic retinopathy market is poised for substantial growth, with an expected CAGR of 5.8% between 2023 and 2033. In 2023, the market is projected to be valued at US$ 8.82 billion. Driven by rising demand for diabetic retinopathy treatments among patients with damaged eye retinas, manufacturers in this sector are anticipated to witness a …
Future of Medicine: Digital Therapeutics Market Surges at 24.4% CAGR, Targets US$ 42.5 Billion by 2032 | FMI
Global Digital Therapeutics Market Surges to US$ 4.8 Bn in 2022, Anticipates Staggering 24.4% CAGR, Poised to Hit US$ 42.5 Bn by 2032 To infiltrate and disrupt the healthcare sector, IT companies are producing and acquiring digital therapies. Players are investigating whether digital medicines might improve quality of life and outcomes while maintaining or lowering …
Navigating the Beauty Landscape: Dermal Fillers Market Set for 7.5% CAGR through 2023-2033, | FMI Reports
The Dermal Fillers Market is poised for substantial growth with a projected Compound Annual Growth Rate (CAGR) of 7.5% during the period spanning 2023 to 2033. These filters find application in rejuvenating diverse facial areas, each serving distinct functional purposes. The market is experiencing a surge in demand, primarily driven by the increasing desire for …
FMI Unveils Middle East Veterinary Vaccines Market’s Remarkable Journey Towards a US$ 533.4 Million Valuation by 2031, Fueled by a 4.8% CAGR
Recent Research by Future Market Insights (FMI) Anticipates Moderate Growth in the Middle East Veterinary Vaccines Market. Expected to Surge from US$ 335.0 Mn in 2021 to Over US$ 533.4 Mn by 2031, Reflecting a Cumulative CAGR of Approximately 4.8% During the Forecast Period (2021-2031). The Middle East region has witnessed a rising demand for …
Charting the Future of Nerve Repair Market: FMI’s Latest Report Forecasts a Resilient 12.2% CAGR, Reaching US$ 861.4 Million by 2033
Global Nerve Repair Market to Exceed US$ 272.4 Million in 2023, Showcasing a Robust 12.2% CAGR Growth from 2023 to 2033. Fueled by the Escalating Incidence of Neurological Disorders, Market Sales are Poised to Reach US$ 861.4 Million by 2033. The rising prevalence of chronic neurological conditions like Alzheimer’s and Parkinson’s disease is expected to …